0000899243-22-034834.txt : 20221102
0000899243-22-034834.hdr.sgml : 20221102
20221102203636
ACCESSION NUMBER: 0000899243-22-034834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221031
FILED AS OF DATE: 20221102
DATE AS OF CHANGE: 20221102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: De Rosch Mark
CENTRAL INDEX KEY: 0001890320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 221355837
MAIL ADDRESS:
STREET 1: C/O AURA BIOSCIENCES, INC.
STREET 2: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-31
0
0001501796
Aura Biosciences, Inc.
AURA
0001890320
De Rosch Mark
C/O AURA BIOSCIENCES, INC.
80 GUEST STREET
BOSTON
MA
01235
0
1
0
0
Chief Operating Officer
Common Stock
2022-10-31
4
S
0
1115
12.4574
D
16385
D
The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Julie Feder, as Attorney-in-Fact
2022-11-02